Satoshi Kashiwagi, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nitric Oxide | 14 | 2024 | 2146 | 1.790 |
Why?
|
| Nitric Oxide Synthase Type III | 10 | 2024 | 706 | 1.660 |
Why?
|
| Infrared Rays | 7 | 2024 | 249 | 1.620 |
Why?
|
| Lasers | 7 | 2022 | 952 | 1.560 |
Why?
|
| Adjuvants, Immunologic | 8 | 2022 | 998 | 1.460 |
Why?
|
| Lasers, Semiconductor | 2 | 2020 | 43 | 1.240 |
Why?
|
| Vaccines | 6 | 2021 | 845 | 1.200 |
Why?
|
| Influenza Vaccines | 5 | 2022 | 781 | 1.070 |
Why?
|
| Vaccination | 5 | 2020 | 3434 | 0.960 |
Why?
|
| Injections, Intradermal | 3 | 2018 | 116 | 0.750 |
Why?
|
| Dendritic Cells | 5 | 2018 | 2757 | 0.670 |
Why?
|
| Skin | 4 | 2018 | 4520 | 0.560 |
Why?
|
| Spectroscopy, Near-Infrared | 3 | 2024 | 752 | 0.520 |
Why?
|
| Fluorescent Dyes | 11 | 2024 | 1924 | 0.520 |
Why?
|
| Nanoparticles | 3 | 2022 | 1986 | 0.450 |
Why?
|
| Mast Cells | 2 | 2018 | 1407 | 0.400 |
Why?
|
| Laser Therapy | 1 | 2018 | 1107 | 0.380 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2013 | 255 | 0.370 |
Why?
|
| Cyclobutanes | 2 | 2022 | 57 | 0.370 |
Why?
|
| Sulfonic Acids | 2 | 2021 | 102 | 0.350 |
Why?
|
| Influenza A virus | 1 | 2013 | 460 | 0.340 |
Why?
|
| Quaternary Ammonium Compounds | 2 | 2021 | 204 | 0.340 |
Why?
|
| Serine | 1 | 2013 | 831 | 0.320 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4642 | 0.310 |
Why?
|
| Animals | 47 | 2024 | 169418 | 0.310 |
Why?
|
| Mice | 34 | 2024 | 82045 | 0.310 |
Why?
|
| Signal Transduction | 5 | 2024 | 23638 | 0.290 |
Why?
|
| Tissue Distribution | 5 | 2023 | 2298 | 0.260 |
Why?
|
| Melanoma, Experimental | 2 | 2009 | 561 | 0.260 |
Why?
|
| Reactive Oxygen Species | 4 | 2022 | 2150 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 14 | 2024 | 22365 | 0.250 |
Why?
|
| Cells, Cultured | 7 | 2022 | 19041 | 0.230 |
Why?
|
| Neoplasms | 7 | 2023 | 22386 | 0.230 |
Why?
|
| Fetal Distress | 1 | 2003 | 39 | 0.220 |
Why?
|
| Fluorescein | 2 | 2006 | 175 | 0.220 |
Why?
|
| Heart Rate, Fetal | 1 | 2003 | 76 | 0.210 |
Why?
|
| Indocyanine Green | 1 | 2024 | 239 | 0.210 |
Why?
|
| Adiposity | 1 | 2013 | 1888 | 0.210 |
Why?
|
| T-Lymphocytes | 2 | 2020 | 10273 | 0.210 |
Why?
|
| Gases | 1 | 2003 | 204 | 0.210 |
Why?
|
| Venules | 1 | 2002 | 161 | 0.200 |
Why?
|
| Phosphorylation | 6 | 2024 | 8332 | 0.200 |
Why?
|
| Microcirculation | 3 | 2003 | 1282 | 0.200 |
Why?
|
| Arterioles | 1 | 2002 | 252 | 0.190 |
Why?
|
| Succinimides | 1 | 2021 | 83 | 0.190 |
Why?
|
| Chemokine CXCL12 | 2 | 2015 | 457 | 0.190 |
Why?
|
| Ovarian Neoplasms | 4 | 2022 | 4906 | 0.180 |
Why?
|
| Phenols | 2 | 2022 | 520 | 0.170 |
Why?
|
| Electron Transport Complex IV | 1 | 2020 | 192 | 0.170 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2003 | 359 | 0.160 |
Why?
|
| Serum | 1 | 2020 | 208 | 0.160 |
Why?
|
| Ovalbumin | 2 | 2019 | 678 | 0.160 |
Why?
|
| Insulin Resistance | 1 | 2013 | 3974 | 0.160 |
Why?
|
| Ionophores | 3 | 2023 | 108 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2022 | 2465 | 0.150 |
Why?
|
| Ions | 1 | 2019 | 257 | 0.150 |
Why?
|
| Nitric Oxide Synthase | 4 | 2006 | 911 | 0.150 |
Why?
|
| Silicon Dioxide | 1 | 2019 | 218 | 0.150 |
Why?
|
| Cerebrovascular Circulation | 3 | 2024 | 2737 | 0.150 |
Why?
|
| Neoplasms, Experimental | 3 | 2008 | 1232 | 0.150 |
Why?
|
| Neovascularization, Pathologic | 4 | 2007 | 2643 | 0.140 |
Why?
|
| Antigen-Presenting Cells | 2 | 2019 | 965 | 0.140 |
Why?
|
| Mannose-Binding Lectins | 1 | 2017 | 96 | 0.140 |
Why?
|
| Cerebrovascular Disorders | 1 | 2024 | 1487 | 0.140 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 15638 | 0.140 |
Why?
|
| Oxidation-Reduction | 1 | 2022 | 2232 | 0.130 |
Why?
|
| Receptors, CCR2 | 1 | 2017 | 216 | 0.130 |
Why?
|
| Immunization | 2 | 2018 | 1220 | 0.130 |
Why?
|
| Cell Movement | 2 | 2018 | 5223 | 0.130 |
Why?
|
| Peritoneal Neoplasms | 1 | 2022 | 715 | 0.130 |
Why?
|
| Endothelium, Vascular | 3 | 2006 | 4425 | 0.120 |
Why?
|
| Carotid Artery Diseases | 1 | 2021 | 879 | 0.120 |
Why?
|
| Endothelial Cells | 3 | 2022 | 3586 | 0.120 |
Why?
|
| Cell Separation | 1 | 2020 | 1726 | 0.110 |
Why?
|
| Lectins, C-Type | 1 | 2017 | 589 | 0.110 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2022 | 1005 | 0.110 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 1195 | 0.110 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 736 | 0.110 |
Why?
|
| Alginates | 1 | 2015 | 250 | 0.110 |
Why?
|
| Lymph Nodes | 2 | 2019 | 3472 | 0.110 |
Why?
|
| Russia | 1 | 2014 | 386 | 0.110 |
Why?
|
| Antigens, Surface | 1 | 2017 | 1615 | 0.100 |
Why?
|
| Glioma | 1 | 2008 | 3523 | 0.100 |
Why?
|
| Contrast Media | 2 | 2023 | 5336 | 0.100 |
Why?
|
| Biological Availability | 2 | 2023 | 390 | 0.100 |
Why?
|
| GPI-Linked Proteins | 1 | 2014 | 473 | 0.100 |
Why?
|
| Rats, Wistar | 6 | 2006 | 1891 | 0.100 |
Why?
|
| Immunotherapy | 3 | 2022 | 4728 | 0.100 |
Why?
|
| omega-N-Methylarginine | 3 | 2009 | 108 | 0.100 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2014 | 395 | 0.100 |
Why?
|
| Flow Cytometry | 2 | 2017 | 5904 | 0.090 |
Why?
|
| Gene Knock-In Techniques | 1 | 2013 | 423 | 0.090 |
Why?
|
| Lung Neoplasms | 3 | 2023 | 13589 | 0.090 |
Why?
|
| Immunocompetence | 1 | 2011 | 139 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 2 | 2009 | 1369 | 0.090 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2021 | 1547 | 0.090 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2015 | 748 | 0.080 |
Why?
|
| Humans | 27 | 2024 | 768451 | 0.080 |
Why?
|
| Vascular Resistance | 1 | 2013 | 941 | 0.080 |
Why?
|
| HIV Antigens | 1 | 2009 | 328 | 0.080 |
Why?
|
| Hyperlipidemias | 1 | 2013 | 773 | 0.070 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 13708 | 0.070 |
Why?
|
| Mesothelioma | 1 | 2014 | 811 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2008 | 175 | 0.070 |
Why?
|
| Liver | 4 | 2004 | 7575 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2020 | 10494 | 0.070 |
Why?
|
| Fibrosarcoma | 1 | 2009 | 313 | 0.070 |
Why?
|
| Disease Models, Animal | 6 | 2024 | 18388 | 0.070 |
Why?
|
| Vascular Diseases | 2 | 2013 | 1162 | 0.070 |
Why?
|
| Models, Biological | 2 | 2019 | 9505 | 0.070 |
Why?
|
| Catechin | 1 | 2007 | 70 | 0.070 |
Why?
|
| Calcium | 1 | 2020 | 5793 | 0.070 |
Why?
|
| Diabetes Complications | 1 | 2013 | 1322 | 0.070 |
Why?
|
| Mice, Knockout | 5 | 2013 | 14480 | 0.070 |
Why?
|
| Receptors, CXCR4 | 1 | 2011 | 729 | 0.070 |
Why?
|
| Antipyrine | 1 | 2006 | 40 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2018 | 3080 | 0.070 |
Why?
|
| Cancer Vaccines | 1 | 2014 | 1044 | 0.070 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2024 | 488 | 0.070 |
Why?
|
| Enzyme Inhibitors | 4 | 2005 | 3734 | 0.060 |
Why?
|
| Free Radical Scavengers | 1 | 2006 | 212 | 0.060 |
Why?
|
| Pregnancy Proteins | 1 | 2006 | 224 | 0.060 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2009 | 925 | 0.060 |
Why?
|
| Mice, Nude | 4 | 2019 | 3635 | 0.060 |
Why?
|
| Radiation Tolerance | 1 | 2007 | 478 | 0.060 |
Why?
|
| Crosses, Genetic | 3 | 2013 | 753 | 0.060 |
Why?
|
| Female | 13 | 2022 | 396943 | 0.060 |
Why?
|
| Kupffer Cells | 1 | 2004 | 143 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2007 | 2633 | 0.050 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2022 | 48 | 0.050 |
Why?
|
| Lymphatic System | 1 | 2004 | 253 | 0.050 |
Why?
|
| Cell Growth Processes | 3 | 2009 | 383 | 0.050 |
Why?
|
| Guanylate Cyclase | 1 | 2003 | 206 | 0.050 |
Why?
|
| Weight Gain | 1 | 2013 | 2357 | 0.050 |
Why?
|
| Splanchnic Circulation | 1 | 2002 | 119 | 0.050 |
Why?
|
| Vitamin E | 1 | 2007 | 873 | 0.050 |
Why?
|
| Brain | 3 | 2019 | 27438 | 0.050 |
Why?
|
| Uterine Hemorrhage | 1 | 2003 | 240 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2014 | 3697 | 0.050 |
Why?
|
| Drug Delivery Systems | 2 | 2023 | 2238 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2008 | 1503 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2024 | 17149 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 8721 | 0.050 |
Why?
|
| Glucose | 1 | 2013 | 4355 | 0.050 |
Why?
|
| Antibodies | 2 | 2020 | 2425 | 0.050 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2004 | 568 | 0.040 |
Why?
|
| Ferrosoferric Oxide | 1 | 2021 | 349 | 0.040 |
Why?
|
| Rats | 6 | 2006 | 23839 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2013 | 3038 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2020 | 542 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2013 | 8538 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2004 | 731 | 0.040 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 3939 | 0.040 |
Why?
|
| Half-Life | 1 | 2019 | 650 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 2430 | 0.040 |
Why?
|
| Skull | 1 | 2023 | 832 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2021 | 586 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2002 | 1685 | 0.040 |
Why?
|
| Protoporphyrins | 2 | 1995 | 170 | 0.040 |
Why?
|
| Heme Oxygenase (Decyclizing) | 2 | 1995 | 167 | 0.040 |
Why?
|
| Gelatin | 1 | 2019 | 230 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2022 | 2488 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2019 | 2173 | 0.040 |
Why?
|
| Stroke | 2 | 2024 | 9791 | 0.030 |
Why?
|
| Nanomedicine | 1 | 2019 | 291 | 0.030 |
Why?
|
| Tail | 2 | 2009 | 90 | 0.030 |
Why?
|
| Fluorescence | 1 | 2019 | 760 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 9558 | 0.030 |
Why?
|
| Male | 13 | 2021 | 364781 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 2003 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 1997 | 408 | 0.030 |
Why?
|
| Oxygen | 1 | 2008 | 4269 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2018 | 890 | 0.030 |
Why?
|
| Photosensitizing Agents | 1 | 2020 | 633 | 0.030 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 489 | 0.030 |
Why?
|
| Gap Junctions | 1 | 1997 | 230 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 1002 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2019 | 1640 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 2640 | 0.030 |
Why?
|
| Particle Size | 1 | 2019 | 1654 | 0.030 |
Why?
|
| Carcinoma | 1 | 2007 | 2341 | 0.030 |
Why?
|
| Ischemia | 1 | 2004 | 1900 | 0.030 |
Why?
|
| Hexuronic Acids | 1 | 2015 | 145 | 0.030 |
Why?
|
| Glucuronic Acid | 1 | 2015 | 150 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2005 | 1890 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 1339 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 3520 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2006 | 3145 | 0.030 |
Why?
|
| Molecular Imaging | 1 | 2021 | 825 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 1997 | 927 | 0.030 |
Why?
|
| Potassium Channels | 1 | 1997 | 538 | 0.030 |
Why?
|
| Electrophysiology | 1 | 1997 | 1266 | 0.030 |
Why?
|
| Systems Biology | 1 | 2017 | 481 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 1997 | 1090 | 0.030 |
Why?
|
| Mutation | 3 | 2013 | 30243 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2019 | 3090 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2015 | 6241 | 0.030 |
Why?
|
| Hydrogels | 1 | 2019 | 745 | 0.030 |
Why?
|
| Calcium Channels | 1 | 1997 | 624 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2017 | 65409 | 0.030 |
Why?
|
| Gene Expression | 1 | 2005 | 7605 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 948 | 0.030 |
Why?
|
| Carbon Monoxide | 1 | 1995 | 551 | 0.020 |
Why?
|
| tau Proteins | 1 | 2023 | 2129 | 0.020 |
Why?
|
| Ion Channels | 1 | 1997 | 1044 | 0.020 |
Why?
|
| HIV-1 | 1 | 2009 | 6966 | 0.020 |
Why?
|
| ROC Curve | 1 | 2019 | 3624 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 1561 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3619 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2004 | 4948 | 0.020 |
Why?
|
| Neutrophils | 1 | 2003 | 3790 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1994 | 1152 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2018 | 8730 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2020 | 5443 | 0.020 |
Why?
|
| Regeneration | 1 | 2019 | 1527 | 0.020 |
Why?
|
| Cell Communication | 1 | 1997 | 1662 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2017 | 1062 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 2039 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 3891 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 12242 | 0.020 |
Why?
|
| Mitochondria | 1 | 2022 | 3672 | 0.020 |
Why?
|
| Apoptosis | 3 | 2011 | 9526 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 11138 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2009 | 127 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2009 | 426 | 0.020 |
Why?
|
| Transfection | 2 | 2007 | 5767 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2009 | 119 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 616 | 0.020 |
Why?
|
| Peptides | 1 | 2020 | 4368 | 0.020 |
Why?
|
| Lymphangiogenesis | 1 | 2009 | 172 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 2705 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2013 | 1461 | 0.020 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2007 | 112 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 1608 | 0.020 |
Why?
|
| Radiation-Protective Agents | 1 | 2007 | 88 | 0.020 |
Why?
|
| Macrophages | 1 | 2021 | 5797 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 548 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2015 | 4834 | 0.020 |
Why?
|
| Electrochemistry | 1 | 2006 | 146 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2017 | 2531 | 0.020 |
Why?
|
| Mesenteric Veins | 1 | 2006 | 87 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2007 | 916 | 0.020 |
Why?
|
| United States | 1 | 2014 | 73121 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 621 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2006 | 455 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 1775 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2006 | 406 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2009 | 1393 | 0.010 |
Why?
|
| Thromboxanes | 1 | 2004 | 45 | 0.010 |
Why?
|
| Dimerization | 1 | 2006 | 888 | 0.010 |
Why?
|
| Kidney | 1 | 2019 | 7064 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 6527 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3816 | 0.010 |
Why?
|
| Fluoresceins | 1 | 2004 | 236 | 0.010 |
Why?
|
| Antigen Presentation | 1 | 2009 | 1251 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2004 | 158 | 0.010 |
Why?
|
| Lymphography | 1 | 2004 | 189 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 6856 | 0.010 |
Why?
|
| Ligation | 1 | 2004 | 447 | 0.010 |
Why?
|
| Bile | 1 | 2004 | 299 | 0.010 |
Why?
|
| Rheology | 1 | 2004 | 349 | 0.010 |
Why?
|
| AIDS Vaccines | 1 | 2009 | 900 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2004 | 518 | 0.010 |
Why?
|
| RNA Interference | 1 | 2011 | 2832 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2006 | 773 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4586 | 0.010 |
Why?
|
| Bilirubin | 1 | 2004 | 439 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2009 | 5042 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2007 | 1749 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9507 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2007 | 1335 | 0.010 |
Why?
|
| Glutathione | 1 | 2004 | 587 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 30179 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2014 | 10125 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 2930 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2009 | 6242 | 0.010 |
Why?
|
| Perfusion | 2 | 1995 | 1402 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2004 | 786 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 1977 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2884 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 21156 | 0.010 |
Why?
|
| Wound Healing | 1 | 2009 | 2819 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 13452 | 0.010 |
Why?
|
| DNA Damage | 1 | 2007 | 2461 | 0.010 |
Why?
|
| Survival Rate | 1 | 2011 | 12875 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2009 | 5152 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 17647 | 0.010 |
Why?
|
| Venous Thrombosis | 1 | 2006 | 1318 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2006 | 4931 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2007 | 8559 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2007 | 3445 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 1994 | 395 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2007 | 5808 | 0.010 |
Why?
|
| Thrombosis | 1 | 2006 | 2956 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2004 | 2399 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 60045 | 0.010 |
Why?
|
| Vasodilation | 1 | 1995 | 968 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1994 | 1502 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 89168 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 9623 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 9066 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 13655 | 0.000 |
Why?
|
| Middle Aged | 1 | 2018 | 223418 | 0.000 |
Why?
|
| Adult | 1 | 2018 | 223542 | 0.000 |
Why?
|
| HIV Infections | 1 | 2009 | 17564 | 0.000 |
Why?
|